NGNE
Price
$22.48
Change
-$0.16 (-0.71%)
Updated
Dec 23, 04:59 PM (EDT)
RNAZ
Price
$3.58
Change
-$0.18 (-4.79%)
Updated
Dec 23, 04:59 PM (EDT)
Ad is loading...

NGNE vs RNAZ

Header iconNGNE vs RNAZ Comparison
Open Charts NGNE vs RNAZBanner chart's image
Neurogene
Price$22.48
Change-$0.16 (-0.71%)
Volume$900
CapitalizationN/A
TransCode Therapeutics
Price$3.58
Change-$0.18 (-4.79%)
Volume$100
CapitalizationN/A
NGNE vs RNAZ Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGNE vs. RNAZ commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and RNAZ is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (NGNE: $22.64 vs. RNAZ: $3.76)
Brand notoriety: NGNE and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 102% vs. RNAZ: 171%
Market capitalization -- NGNE: $334.23M vs. RNAZ: $2.49M
NGNE [@Biotechnology] is valued at $334.23M. RNAZ’s [@Biotechnology] market capitalization is $2.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both NGNE and RNAZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 4 TA indicator(s) are bullish while RNAZ’s TA Score has 3 bullish TA indicator(s).

  • NGNE’s TA Score: 4 bullish, 4 bearish.
  • RNAZ’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both NGNE and RNAZ are a good buy in the short-term.

Price Growth

NGNE (@Biotechnology) experienced а -3.70% price change this week, while RNAZ (@Biotechnology) price change was -49.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.79%. For the same industry, the average monthly price growth was -2.59%, and the average quarterly price growth was +3.59%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 14, 2023.

RNAZ is expected to report earnings on May 23, 2023.

Industries' Descriptions

@Biotechnology (-1.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($334M) has a higher market cap than RNAZ($2.57M). NGNE YTD gains are higher at: 16.821 vs. RNAZ (-98.272). RNAZ has higher annual earnings (EBITDA): -14.33M vs. NGNE (-49.96M). NGNE has more cash in the bank: 139M vs. RNAZ (1.88M). RNAZ has less debt than NGNE: RNAZ (152K) vs NGNE (14.5M). NGNE has higher revenues than RNAZ: NGNE (925K) vs RNAZ (0).
NGNERNAZNGNE / RNAZ
Capitalization334M2.57M12,996%
EBITDA-49.96M-14.33M349%
Gain YTD16.821-98.272-17%
P/E RatioN/A0.00-
Revenue925K0-
Total Cash139M1.88M7,409%
Total Debt14.5M152K9,539%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNERNAZ
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NYVTX25.680.23
+0.90%
Davis NY Venture A
FEREX10.380.09
+0.87%
First Eagle Global Real Assets I
IYBIX23.730.19
+0.81%
Delaware Ivy Balanced Fund Class I
ESMYX13.980.07
+0.50%
Invesco EQV Euro Small Company Y
TEMUX13.450.04
+0.30%
Morgan Stanley Pathway Em Mkts Eq

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+2.56%
BRNS - NGNE
51%
Loosely correlated
+8.82%
RNAZ - NGNE
48%
Loosely correlated
-2.34%
SNDX - NGNE
41%
Loosely correlated
+1.79%
BPTSY - NGNE
38%
Loosely correlated
N/A
ZNTL - NGNE
37%
Loosely correlated
+2.39%
More

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
-2.34%
NGNE - RNAZ
48%
Loosely correlated
+2.56%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
+2.54%
EDSA - RNAZ
31%
Poorly correlated
-1.14%
More